• slide

    Current practice insights into the use of biologicals

  • slide

    Rapid access to our in-house patient-centric Database Network

  • slide

    An experienced sparring partner for your European healthcare questions

  • slide

    Dedicated to research real-life health care for the benefit of patients

  • News

    Thank you for a great time at ICPE Prague

    The PHARMO team had a great time at ICPE in Prague. It was a great opportunity to meet all the experts in the field and to (re)connect with our clients and partners. At ICPE we had the opportunity to present several aspects of our work, including ...

    PHARMO’s annual scientific report 2017 available

    PHARMO's annual scientific report discusses the current expertise and research of the PHARMO Institute, publications, international collaborations and partners. Furthermore the annual report describes the organisational structure and information on h...

    Comparable paediatric safety profiles of proton pump inhibitors and histamine-2 receptor antagonists

    Hospitalisation rates for predefined safety outcomes (gastroenteritis, convulsion/seizure, pneumonia, thrombocytopenia, acute interstitial nephritis, angioneurotic oedema and failure to thrive) were low and mostly similar in paediatric first-time use...

  • Events

    Real-world Patient Treatment Journeys in Combination with Health Assessments at Critical Drug-changing Time Points

    Presentation at the PhUSE Single Day Event (SDE) on Friday the 21st of September, Brussels, Belgium. Berber Snoeijer consultant at the PHARMO Intitute will present Real-world Patient Treatment Journeys in Combination with Health Assessments at Cr...

    Meet us at ISPOR in Barcelona!

    Meet us at the ISPOR 21th Annual European Congress in Barcelona this week. The PHARMO team welcomes you at our booth #125. We are pleased to announce that 8 of our studies will be presented at the ISPOR in the fields of (amongst others) oncology, dia...

  • Vacancy

    BIG Data Scientist/Statistical Programmer

    BIG Data scientist/Statistical Programmer     True to our mission to excel in the interests of improving patient treatment and care, we operate in an entrepreneurial and multidisciplinary environment. The specialists we recruit are...

  • icon

    What we do

    As an independent research organisation dedicated to the study of epidemiology, drug utilisation, drug safety, health outcomes, and utilisation of healthcare resources PHARMO assists its clients in their decision-making.

  • icon

    What we have

    PHARMO Database Network: we have rapid access to our rich population-based network of databases. Data are derived from different primary and secondary healthcare settings. For our observational studies disease-specific cohorts are created from the various databases.


  • Chemotherapy for ovarian cancer in the Netherlands: a population-based study on treatment patterns and outcomes

    Read more
  • Patterns of antiplatelet drug use after a first myocardial infarction during a 10-year period

    Read more
  • No decreased risk of gastrointestinal cancers in users of metformin in The Netherlands; a time-varying analysis of metformin exposure

    Read more
  • Antipsychotic drug use associated with urinary tract infections in older women

    Read more